RKL Wealth Management LLC Has $1.78 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RKL Wealth Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 43.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 3,526 shares of the healthcare conglomerate’s stock after acquiring an additional 1,060 shares during the quarter. RKL Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,784,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth $37,000. Finally, Legacy Investment Solutions LLC bought a new position in UnitedHealth Group during the third quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.2 %

Shares of NYSE UNH opened at $493.35 on Friday. The firm’s 50-day simple moving average is $513.78 and its 200 day simple moving average is $553.76. The company has a market cap of $451.28 billion, a price-to-earnings ratio of 31.83, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.70%. UnitedHealth Group’s payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $629.32.

Get Our Latest Report on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.